• locale

  United States

• market

  STOCKS

• industry

  Biotechnology

• website

  www.pharming.com

• ipo date

  Dec 23, 2020

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from...Show More

*Estimate based on analyst consensus